Restoration of wild-type p53 by p53-reactivating small molecular weight compounds such as PRIMA-1 (ARP-246) induces p53 target gene expression (such as p21, Puma, and Noxa), triggers cell death, and suppresses tumor growth in vivo. This evidence concerns the gene TP53 and neoplasm.